VSNT:NASDAQVersant Media Group, Inc. Analysis
Data as of 2026-03-14 - not real-time
$37.55
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Versant Media Group trades at $37.55, roughly 2.5% below its DCF fair value of $46.76, and its trailing P/E of 5.8 is dramatically lower than the entertainment industry average of 17.8, suggesting a *potential value cushion*. Revenue has contracted 6.6% year‑over‑year, yet the company still delivers a solid 56% gross margin and a 13% operating margin, indicating resilient profitability. The balance sheet is strained with a debt‑to‑equity ratio of 9.45 and $983 million of debt against only $55 million of cash, raising concerns about dividend sustainability despite a 3.99% yield. On the technical side, the stock sits comfortably above its 20‑day ($33.37) and 50‑day ($33.27) moving averages, the MACD is bullish, and volume is increasing, but the RSI of 68 hints at near‑term overbought conditions as price approaches the $38.65 resistance level.
Given the low beta of 0.22, the stock’s price moves less than the broader market, while 30‑day volatility remains high at 43%, reflecting sector‑specific swings in media consumption. The combination of modest upside, strong cash flow generation ($565 million free cash flow), and a high dividend yield makes VSNT attractive to income‑focused investors, but the ongoing revenue decline and leverage suggest a cautious stance. Overall, the fundamentals point to a *fairly valued* but *value‑oriented* play, with short‑term price pressure near resistance and medium‑to‑long‑term upside limited by structural challenges.
Given the low beta of 0.22, the stock’s price moves less than the broader market, while 30‑day volatility remains high at 43%, reflecting sector‑specific swings in media consumption. The combination of modest upside, strong cash flow generation ($565 million free cash flow), and a high dividend yield makes VSNT attractive to income‑focused investors, but the ongoing revenue decline and leverage suggest a cautious stance. Overall, the fundamentals point to a *fairly valued* but *value‑oriented* play, with short‑term price pressure near resistance and medium‑to‑long‑term upside limited by structural challenges.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish MACD and price above short‑term moving averages
- RSI approaching overbought levels near resistance
- High dividend yield but leverage concerns
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Undervalued relative to peers (low P/E)
- Revenue contraction and high debt load
- Stable cash flow supporting dividend
Long Term
> 3 yearsPositive
Model confidence: 6/10
Key Factors
- Significant valuation gap to DCF fair value
- Attractive dividend yield for income investors
- Low market beta offering defensive characteristics
Key Metrics & Analysis
Financial Health
Revenue Growth-6.60%
Profit Margin13.91%
P/E Ratio5.8
ROE8.73%
ROA6.52%
Debt/Equity9.45
P/B Ratio0.5
Op. Cash Flow$2.0B
Free Cash Flow$565.9M
Industry P/E17.8
Technical Analysis
TrendNeutral
RSI67.7
Support$27.37
Resistance$38.65
MA 20$33.37
MA 50$33.27
MA 200$35.70
MACDBullish
VolumeIncreasing
Fear & Greed Index72.88
Valuation
Fair Value$46.76
Target Price$38.50
Upside/Downside2.53%
GradeFair
TypeValue
Dividend Yield3.99%
Risk Assessment
Beta0.22
Volatility42.99%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.